Friess Associates LLC Bristol Myers Squibb CO Transaction History

Friess Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $13.2 Million - $15.4 Million	-240,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $11.1 Million - $16.2 Million	240,000 New	240,000 $13.4 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $12.4 Million - $15.4 Million	-245,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $14.7 Million - $16.9 Million	245,200 New	245,200 $15.5 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.